GLP-1 agonists can play a useful role, but they are not magic solutions
doi:10.1016/j.obpill.2025.100205 Ben-Porat T, Sherf-Dagan S, Ct M, Miner CJ, Buch A
Paxlovid (nirmatrelvir/ritonavir) Disease area(s): Infectious diseases (antivirals) Manufacturer(s): Pfizer 2024 Sales (USD): $5.72 billion Why it sold so well: In 2024, Pfizers COVID-19 antiviral treatment, Paxlovid, generated $5.72 billion in global revenue, making it the companys third-highest-selling product for the year
Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase)
Heres how the liposomal products are superior: Superior bioavailability: Liposomes protect glutathione from stomach acid and enzymes, leading to much higher absorption than standard oral glutathione